Japanese encephalitis (JE) is an acute infectious disease caused by the Japanese encephalitis virus, a member of the flavivirus family. The main vectors of the virus are mosquitoes of the genus Culex. The infection can lead to deposits in the central nervous system, causing meningoencephalitis, which leads to serious neurological complications and high mortality. It is important to note that not all infected patients show symptoms, but some may develop the disease with severe clinical manifestations such as high fever, headaches, seizures, and coma. Long-term neurological recovery is possible, but does not always occur.
History of the disease and interesting historical facts
Japanese encephalitis has been known since ancient times. The first descriptions of the disease were documented in Japan in the late 19th century, and research into its clinical manifestations continued throughout the 20th century. In 1935, Japanese scientists isolated the virus from pig brain tissue, which was an important step in understanding the etiology and pathogenesis of the disease. The JE epidemic affected not only Japan, but also other East Asian countries, such as India, China, and the Philippines. Mass vaccination since the 1950s has led to a significant decrease in the number of cases in the affected regions. However, JE remains a serious public health problem in countries with a humid tropical climate to this day.
Epidemiology
According to the World Health Organization, about 3 billion people live in areas at risk of contracting Japanese encephalitis. It is estimated that about 68,000 cases of the disease are registered annually, of which about 13,600 are fatal. Also, modern research highlights that among those infected, about 30-50% patients may experience long-term neurological sequelae. Regions with limited access to health services and preventive vaccines account for the largest proportion of cases, which highlights the need for global vaccination programs and medical monitoring.
Genetic predisposition to this disease
For Japanese encephalitis, genetic susceptibility studies are still in their infancy. However, genes involved in the immune response have been shown to play a key role in the development of the disease. Genes such as HLA-DQ and HLA-DR may influence susceptibility to the Japanese encephalitis virus. Certain gene polymorphisms involved in immune modulation and inflammatory response have been associated with increased risk of infection. However, further studies are needed to definitively confirm genetic susceptibility to JE.
Risk factors for the development of this disease
Risk factors for Japanese encephalitis can be classified into several categories, including environmental, biological, and behavioral:
- Environmental: high humidity, stagnant water, presence of agricultural land where mosquitoes are carried.
- Biological: age (children are more susceptible), existing immunosuppressive conditions.
- Behavioural: Outdoor activities, travel to rural areas in East and Southeast Asia.
Understanding these factors is important for developing effective disease prevention and control strategies.
Diagnosis of this disease
The main clinical association of Japanese encephalitis is an acute form of meningitis or meningoencephalitis. The main symptoms include:
- High temperature (fever).
- Headache.
- Cramps.
- Diffuse neurological symptoms (paralysis, impaired consciousness).
Laboratory tests include serologic tests to detect IgM antibodies to the JE virus, as well as PCR to detect viral RNA in the cerebrospinal fluid or blood. Radiologic tests, such as MRI of the brain, may show swelling and other changes characteristic of encephalitis. Additional diagnostics may include tests for other viral infections to differentiate, such as Lyme disease and viruses that cause meningitis.
Treatment
There is currently no specific antiviral treatment for Japanese encephalitis. The treatment approach is supportive care, which includes:
- Hospitalization and monitoring of the patient's condition.
- Parenteral administration of fluids.
- Reduction of fever and symptomatic treatment.
- Use of anticonvulsants if necessary.
Pharmacological treatment may include the use of corticosteroids in cases of severe inflammation, but the effectiveness of this therapy remains controversial. Surgical methods may be necessary in the presence of late complications such as epilepsy. Other treatments may include rehabilitation programs to restore neurological function.
List of medications used to treat this disease
Drugs used to treat the symptoms and complications of Japanese encephalitis include:
- Dextromethorphan (to reduce cough reflexes).
- Phenytoin (to control seizures).
- Ibuprofen or Paracetamol (to reduce fever).
- Corticosteroids (as indicated).
It is important to note that these drugs are used only for symptomatic treatment and do not affect the virus itself.
Disease monitoring
Monitoring of a patient with Japanese encephalitis includes:
- Regular assessment of neurological function.
- Monitoring laboratory parameters for the presence of the virus.
- Evaluation of neurological recovery several months after discharge.
The prognosis of the disease varies depending on the severity of the disease at the time of treatment. Complications may include chronic neurological disorders such as epilepsy, as well as cognitive impairment.
Age-related features of the disease
Japanese encephalitis most often affects children aged 0 to 15 years, as their immune defenses have not yet been developed sufficiently. Adults can also be susceptible to the disease, but their natural defenses to the virus may be higher, especially if they have had the infection in the past. In older people, JE may be more severe, as pre-existing comorbid conditions and weakened immunity aggravate the clinical picture.
Questions and Answers
- How is Japanese encephalitis virus transmitted? The virus is transmitted through the bites of infected Culex mosquitoes that live in certain geographic regions.
- Are there vaccines against Japanese encephalitis? Yes, there are several types of vaccines that are quite effective in protecting against the virus and are recommended for people planning to travel to endemic areas.
- What are the main symptoms of Japanese encephalitis? The main symptoms include fever, headache, difficulty breathing, seizures and changes in consciousness.
- Is it possible to avoid the disease? Yes, taking precautions such as using repellents and getting vaccinated can reduce the risk of infection.
- What are the prospects for recovery from Japanese encephalitis? The prognosis depends on the severity of the disease; some patients may experience serious neurological sequelae, while others may make a full recovery.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov emphasizes the importance of vaccination as the main method of preventing Japanese encephalitis, especially for people traveling to endemic areas. He also recommends regular examinations at the first signs of symptoms to minimize the risk of complications. Using repellents, wearing protective clothing, and avoiding walks near water during mosquito season significantly reduces the likelihood of bites. "Remember that prevention is always better than cure," the doctor concludes.
